资讯

President Donald Trump's budget proposal for fiscal year 2026 requests significant reductions to HIV prevention and ...
In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community ...
The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, ...
Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they ...
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...
吉利德科学于2025年6月18日宣布,美国食品药品监督管理局(FDA)已批准其注射用HIV-1 衣壳抑制剂Yeztugo®(来那帕韦)作为HIV暴露前预防(PrEP)药物,以降低35 公斤及以上体重的成年人和青少年通过性行为感染 HIV 的风险。这标志着Yeztugo®成为在美国首个也是唯一一个一年仅需给药两次的 PrEP选择。研究数据显示,在3期临床研究PURPOSE 1 和 PURPOSE 2 ...
The COVID-19 pandemic paused many HIV prevention efforts, which helped fuel last year's rise in new infections. President ...
The CDC has withdrawn $200,000 in annual HIV prevention funding from AVOL Kentucky, a community-based nonprofit. This decision, part of a national funding overhaul, shifts resources away from ...
At the beginning of June, the Texas Department of State Health Services asked all programs funded by the CDC’s HIV Prevention ...
Learn what a negative HIV test means, why the window period matters, and when you should consider retesting. Essential health ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...